🌅 Pre-Market Pulse

S&P Futures 7,410.25 ▼ -15.00 (-0.20%)	Nasdaq Futures 29,204.75 ▼ -121.50 (-0.41%)	Dow Futures 49,752.00 ▼ -16.00 (-0.03%)
10Y Treasury 4.41% ▲ +0.05%	US Dollar 98.27 ▲ +0.12 (+0.12%)	Bitcoin $80,539 ▼ -$1,188 (-1.45%)

Good morning! Tuesday, May 12 is arriving with a slightly softer tone across the board, and honestly, the news flow this morning is doing its best to keep things interesting. From a jaw-dropping acquisition rejection to a pharmaceutical breakthrough that could rewrite obesity treatment, there is no shortage of storylines competing for your attention. Here is what is moving markets before the bell.

👀 What to Watch Today

The macro calendar is relatively light today, but that does not mean traders are short on things to watch. Treasury yields are creeping higher again, with the 10-year sitting at 4.41 percent this morning. That kind of pressure on rates tends to weigh on growth and tech names, which helps explain why Nasdaq futures are leading the losses at down 0.41 percent.

On the corporate side, the biggest scheduled watch is how the market digests the overnight news cycle. The GameStop and eBay saga will draw retail trader attention, while Nvidia's geopolitical chip situation warrants a close eye on the semiconductor sector broadly. Any commentary from Fed officials today could also shift the yield picture quickly, so keep one ear open for any scheduled remarks.

The dollar index at 98.27 is nudging higher, which adds a quiet headwind for multinational earnings and commodity prices. Bitcoin is also soft at just above 80,500, a signal that risk appetite is measured heading into Tuesday's open.

The “secret weapon” behind Microsoft, Meta, Amazon, and Google [ad]

🌏 Overnight Recap

European markets opened cautiously this morning following a round of corporate news that was more mixed than decisive. Lufthansa announced it will increase its stake in ITA Airways to 90 percent in a deal valued at around 400 million dollars, giving the German carrier a dominant foothold in Italian aviation. Shares of DLAKF are worth watching for any spillover reaction.

Bayer posted a solid 9 percent rise in Q1 operating profit, powered by its crop protection division, offering a rare bright spot for the embattled German chemical giant. Roche also grabbed headlines by securing its second European regulatory approval for an Alzheimer's blood test, a meaningful step forward in the race to detect the disease earlier and more affordably.

Out of Asia, markets were generally mixed with no single dominant catalyst. The broader tone remains one of cautious positioning as investors continue to process trade dynamics and the evolving US-China relationship, particularly as it pertains to technology exports.

Silver paying 20% dividend. Plus 68% share gains [ad]

📊 Pre-Market Movers

Nvidia (NVDA) is pulling back in pre-market after reports surfaced that CEO Jensen Huang was notably absent from President Trump's recent China diplomatic trip. For a company hoping to navigate chip export restrictions and re-enter the Chinese market, that kind of optics matters. The stock had recently hit new highs, so any pullback should be watched carefully for whether it becomes a buying opportunity or a warning sign.

GameStop (GME) is the wildcard of the morning after its audacious 56 billion dollar bid for eBay was flatly rejected. EBAY cited financing concerns and pointed to its own turnaround progress as reasons to stay independent. Both tickers will attract speculative interest early in the session, and GME in particular has a history of outsized moves on far less dramatic news.

Novo Nordisk (NVO) is getting a fresh look after new data showed its higher-dose Wegovy producing 28 percent weight loss in some patients, with most of the reduction coming from body fat rather than muscle. That is a meaningful clinical distinction and could give NVO a renewed catalyst heading into a session where the broader market lacks a clear directional conviction.

While the world watches Iran … this is about to happen [ad]

🔍 Today's Watchlist

1. NVDA: Watch for volatility after reports that CEO Jensen Huang was excluded from Trump's China trip, clouding the chip sales outlook
2. GME and EBAY: The rejected 56 billion dollar offer is a retail trader magnet and both stocks could see elevated volume at the open
3. NVO: Novo Nordisk's higher-dose Wegovy showing 28 percent weight loss could reignite momentum in the GLP-1 trade across the sector
4. Treasury yields: The 10-year at 4.41 percent and 30-year approaching 5 percent are key levels that could pressure rate-sensitive equities
5. AMZN: The 30-minute delivery rollout is a logistics flex worth watching as it puts pressure on competitors and signals aggressive capex deployment

🎯 The Morning Playbook

The setup for Tuesday is one of selective caution rather than broad pessimism. Futures are soft but not alarmed, yields are elevated but stable, and the news flow offers both risks and opportunities depending on where you are positioned. The tech trade, led by names like NVDA and AMZN, will likely set the early tone for the Nasdaq.

The pharma sector deserves attention today. Between NVO's weight loss data, Roche's Alzheimer's approval, Bayer's earnings beat, and the Bristol Myers Squibb licensing deal worth 15.2 billion dollars with Jiangsu Hengrui (BMY), healthcare is quietly having a strong morning. If you have been underweight the sector, today might prompt a second look.

Markets are not falling apart here, they are recalibrating. The stories that matter most today are the ones sitting at the intersection of policy, innovation, and global trade. Stay curious, stay nimble, and do not let a 0.20 percent futures dip define your entire day.

My #1 AI stock for 2026 (name & ticker inside) [ad]